X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (8101) 8101
Book Chapter (32) 32
Magazine Article (4) 4
Newsletter (2) 2
Book Review (1) 1
Reference (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (7049) 7049
drug-eluting stents (5356) 5356
male (4705) 4705
cardiac & cardiovascular systems (4566) 4566
female (4156) 4156
treatment outcome (4005) 4005
middle aged (3806) 3806
aged (3692) 3692
stents (2625) 2625
time factors (2568) 2568
stent (2335) 2335
risk factors (2128) 2128
thrombosis (2059) 2059
percutaneous coronary intervention (2043) 2043
drug-eluting stents - adverse effects (2007) 2007
prosthesis design (1850) 1850
coronary artery disease - therapy (1829) 1829
coronary angiography (1823) 1823
implantation (1752) 1752
angioplasty, balloon, coronary - adverse effects (1592) 1592
cardiovascular (1591) 1591
drug-eluting stent (1553) 1553
restenosis (1432) 1432
percutaneous coronary intervention - adverse effects (1369) 1369
angioplasty, balloon, coronary - instrumentation (1327) 1327
angioplasty (1298) 1298
sirolimus - administration & dosage (1293) 1293
follow-up studies (1252) 1252
prospective studies (1200) 1200
percutaneous coronary intervention - instrumentation (1096) 1096
risk assessment (1089) 1089
cardiovascular agents - administration & dosage (1086) 1086
abridged index medicus (1074) 1074
cardiology (1052) 1052
retrospective studies (998) 998
coronary restenosis - etiology (982) 982
bare-metal stents (971) 971
outcomes (946) 946
myocardial infarction - etiology (894) 894
transluminal angioplasty (874) 874
registries (865) 865
intervention (841) 841
coronary artery disease - mortality (818) 818
kaplan-meier estimate (800) 800
coronary heart disease (795) 795
care and treatment (787) 787
coronary artery disease (781) 781
platelet aggregation inhibitors - therapeutic use (765) 765
follow-up (761) 761
heart attacks (752) 752
thrombosis - etiology (746) 746
mortality (745) 745
coronary artery disease - diagnostic imaging (744) 744
analysis (742) 742
paclitaxel - administration & dosage (736) 736
surgery (733) 733
aged, 80 and over (731) 731
sirolimus - analogs & derivatives (707) 707
peripheral vascular disease (687) 687
coronary restenosis - prevention & control (676) 676
coronary thrombosis - etiology (663) 663
coronary artery disease - surgery (660) 660
revascularization (655) 655
trial (645) 645
cardiac patients (624) 624
metals (624) 624
coronary vessels (604) 604
lesions (593) 593
paclitaxel (585) 585
coronary stenosis - therapy (573) 573
platelet aggregation inhibitors - administration & dosage (573) 573
angioplasty, balloon, coronary - mortality (565) 565
cardiovascular disease (565) 565
angioplasty, balloon, coronary (560) 560
percutaneous coronary intervention - mortality (560) 560
animals (558) 558
myocardial infarction (558) 558
stents - adverse effects (558) 558
artery-disease (556) 556
optical coherence tomography (556) 556
cardiology and cardiovascular medicine (554) 554
angioplasty, balloon, coronary - methods (547) 547
ticlopidine - analogs & derivatives (547) 547
proportional hazards models (545) 545
percutaneous coronary intervention - methods (541) 541
clinical-outcomes (540) 540
sirolimus (539) 539
metaanalysis (530) 530
myocardial-infarction (528) 528
clopidogrel (525) 525
predictive value of tests (525) 525
disease (521) 521
adult (517) 517
coronary vessels - pathology (515) 515
myocardial infarction - therapy (515) 515
medicine, general & internal (509) 509
intravascular ultrasound (506) 506
implants (495) 495
patients (489) 489
incidence (483) 483
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (7980) 7980
Japanese (93) 93
German (36) 36
Chinese (31) 31
Russian (29) 29
Spanish (28) 28
Polish (16) 16
Italian (14) 14
Portuguese (14) 14
French (12) 12
Turkish (5) 5
Korean (4) 4
Danish (3) 3
Czech (2) 2
Lithuanian (1) 1
Norwegian (1) 1
Serbian (1) 1
Swedish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of the American College of Cardiology, ISSN 0735-1097, 03/2015, Volume 65, Issue 8, pp. 777 - 786
Background The currently recommended duration of dual antiplatelet therapy (DAPT) in drug-eluting stent... 
double antiplatelet duration | percutaneous coronary angioplasty | CARDIAC & CARDIOVASCULAR SYSTEMS | MYOCARDIAL-INFARCTION | THROMBOSIS | BARE-METAL STENTS | FOLLOW-UP | RISK | PERCUTANEOUS CORONARY INTERVENTION | IMPACT | POOLED ANALYSIS | CLINICAL-OUTCOMES | PLATELET REACTIVITY | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Postoperative Complications - prevention & control | Male | Hemorrhage - prevention & control | Aspirin - administration & dosage | Drug-Eluting Stents - adverse effects | Middle East | Early Termination of Clinical Trials | Coronary Restenosis - diagnosis | Coronary Artery Disease - physiopathology | Time Factors | Aspirin - adverse effects | Percutaneous Coronary Intervention - methods | Hemorrhage - etiology | Platelet Aggregation Inhibitors - administration & dosage | Ticlopidine - adverse effects | Ticlopidine - administration & dosage | Female | Everolimus | Coronary Restenosis - etiology | Platelet Aggregation Inhibitors - adverse effects | Coronary Vessels - pathology | Sirolimus - analogs & derivatives | Sirolimus - therapeutic use | Europe | Coronary Restenosis - prevention & control | Treatment Outcome | Coronary Artery Disease - mortality | Postoperative Complications - diagnosis | Ticlopidine - analogs & derivatives | Coronary Artery Disease - therapy | Coronary Artery Disease - diagnosis | Coronary Vessels - surgery | Aged | Percutaneous Coronary Intervention - adverse effects | Aspirin
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2011, Volume 377, Issue 9784, pp. 2193 - 2204
... by selection of the optimal antithrombotic regimen and stent type for intervention. Bleeding complications and transfusions have emerged as major independent predictors... 
Internal Medicine | HARMONIZING OUTCOMES | MEDICINE, GENERAL & INTERNAL | BLOOD-TRANSFUSION | DOUBLE-BLIND | FOLLOW-UP | ACUTE CORONARY SYNDROMES | ST-SEGMENT ELEVATION | PREMATURE DISCONTINUATION | INTERVENTION | ANTIPLATELET THERAPY | CLINICAL-OUTCOMES | Confidence Intervals | Myocardial Infarction - mortality | Paclitaxel - pharmacology | Prospective Studies | Follow-Up Studies | Humans | Heparin - administration & dosage | Male | Recombinant Proteins - adverse effects | Heparin - adverse effects | Hirudins - administration & dosage | Dose-Response Relationship, Drug | Myocardial Infarction - therapy | Platelet Glycoprotein GPIIb-IIIa Complex - administration & dosage | Time Factors | Electrocardiography | Female | Drug Therapy, Combination | Stents | Angioplasty, Balloon - methods | Myocardial Infarction - diagnosis | Drug-Eluting Stents | Drug Administration Schedule | Peptide Fragments - administration & dosage | Kaplan-Meier Estimate | Treatment Outcome | Combined Modality Therapy | Recombinant Proteins - administration & dosage | Platelet Glycoprotein GPIIb-IIIa Complex - antagonists & inhibitors | Angioplasty, Balloon - mortality | Hirudins - adverse effects | Survival Analysis | Peptide Fragments - adverse effects | Bivalirudin | Research | Diagnosis | Heparin | Drug therapy | Comparative analysis | Health aspects | Heart attack | Heart attacks | Cardiology | Mortality
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 2015, Volume 65, Issue 8, pp. 805 - 815
Abstract Background The use of drug-eluting stents (DES) in patients at high risk of bleeding or thrombosis has not been prospectively studied... 
Cardiovascular | Internal Medicine | dual-antiplatelet therapy | high bleeding risk | high thrombotic risk | zotarolimus-eluting stent(s) | drug-eluting stent(s) | dualantiplatelet therapy | DESIGN | CARDIAC & CARDIOVASCULAR SYSTEMS | NEOINTIMAL COVERAGE | ANGIOPLASTY | IMPLANTATION | POLYMER | ACUTE MYOCARDIAL-INFARCTION | OUTCOMES | DURATION | Coronary Artery Disease - surgery | Humans | Immunosuppressive Agents - therapeutic use | Postoperative Complications - prevention & control | Male | Hemorrhage - prevention & control | Aspirin - administration & dosage | Drug-Eluting Stents - adverse effects | Coronary Restenosis - diagnosis | Coronary Angiography - methods | Aspirin - adverse effects | Percutaneous Coronary Intervention - methods | Hemorrhage - etiology | Platelet Aggregation Inhibitors - administration & dosage | Ticlopidine - adverse effects | Aged, 80 and over | Ticlopidine - administration & dosage | Female | Coronary Restenosis - etiology | Platelet Aggregation Inhibitors - adverse effects | Sirolimus - analogs & derivatives | Sirolimus - therapeutic use | Risk Assessment | Risk Factors | Coronary Restenosis - prevention & control | Treatment Outcome | Postoperative Complications - diagnosis | Ticlopidine - analogs & derivatives | Coronary Artery Disease - diagnosis | Aged | Biocompatible Materials - therapeutic use | Percutaneous Coronary Intervention - adverse effects | Sects | Stent (Surgery) | Heart attacks | Drug therapy | Stents | Coronary vessels
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 02/2008, Volume 51, Issue 6, pp. 618 - 626
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2014, Volume 371, Issue 23, pp. 2155 - 2166
.... Continued therapy resulted in lower rates of stent thrombosis and major adverse cardiovascular events but more bleeding... 
TRIALS | MEDICINE, GENERAL & INTERNAL | PERCUTANEOUS CORONARY INTERVENTION | MULTICENTER | CLOPIDOGREL | TICAGRELOR | THROMBOSIS | RATIONALE | PREVENTION | ASPIRIN | CLINICAL-OUTCOMES | Piperazines - administration & dosage | Prasugrel Hydrochloride | Thiophenes - adverse effects | Humans | Middle Aged | Male | Thiophenes - administration & dosage | Aspirin - administration & dosage | Incidence | Time Factors | Aspirin - adverse effects | Platelet Aggregation Inhibitors - administration & dosage | Ticlopidine - adverse effects | Ticlopidine - administration & dosage | Female | Myocardial Ischemia - mortality | Thrombosis - prevention & control | Drug Therapy, Combination | Myocardial Ischemia - epidemiology | Platelet Aggregation Inhibitors - adverse effects | Drug-Eluting Stents | Drug Administration Schedule | Piperazines - adverse effects | Ticlopidine - analogs & derivatives | Myocardial Ischemia - therapy | Aged | Hemorrhage - chemically induced | Aggregation | Treatment outcome | Care and treatment | Usage | Blood platelets | Analysis | Drug-eluting stents | Dosage and administration | Cardiovascular diseases | Thrombosis | Health aspects | Blood clot | Myocardial infarction | Cerebral infarction | Aspirin | Stroke | Drug delivery | Patients | Bleeding | Clinical outcomes | Cerebrovascular system | Coronary vessels | Implants | Clopidogrel | Drug therapy | Stents
Journal Article
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2012, Volume 379, Issue 9824, pp. 1393 - 1402
Journal Article